Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About LMND Interactive Breakdown Better Bets vs. LMND Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Lemonade (LMND)

Market Price (10/31/2025): $59.86 | Market Cap: $4.4 Bil
Sector: Financials | Industry: Property & Casualty Insurance

Lemonade (LMND)

Market Price (10/31/2025): $59.86
Market Cap: $4.4 Bil
Sector: Financials
Industry: Property & Casualty Insurance

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -12%		 Trading close to highs
Dist 52W High is -3.2%, Dist 3Y High is -3.2%		 Stock price has recently run up significantly
6M Rtn6 month market price return is 107%, 12M Rtn12 month market price return is 215%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 28%		  Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -3.6%
2   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -9.2%
3   Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 21%
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -12%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 28%
2 Trading close to highs
Dist 52W High is -3.2%, Dist 3Y High is -3.2%
3 Stock price has recently run up significantly
6M Rtn6 month market price return is 107%, 12M Rtn12 month market price return is 215%
4 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.9%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -3.6%
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -9.2%
6 Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 21%

Market Valuation & Key Metrics

LMNDS&P 500
REVENUE GROWTHVERY GOOD
Rev LTM ($ Bil)0.6
Rev Chg Q34.5%6.4%
Rev Chg LTM27.5%5.4%
Rev Chg 3Y Avg56.5%5.3%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)�
CFO LTM ($ Bil)-0.0
Net Inc LTM ($ Bil)-0.2
CFO/Rev LTM-1.9%20.4%
Net Inc Mgn-34.0%12.8%
VALUATIONHIGH
P/S7.33.2
P/CFO-378.915.5
P/FCF-205.420.6
P/E-21.523.6

LMND Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 107.0% change in LMND stock from 5/1/2025 to 10/30/2025 was primarily driven by a 85.2% change in the company's P/S Multiple.

501202510302025Change
Stock Price ($)28.5159.01106.98%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)526.50600.7014.09%
P/S Multiple3.907.2185.17%
Shares Outstanding (Mil)71.9473.43-2.07%
Cumulative Contribution106.89%

LTM = Last Twelve Months as of date shown
The 214.7% change in LMND stock from 10/30/2024 to 10/30/2025 was primarily driven by a 156.3% change in the company's P/S Multiple.

1030202410302025Change
Stock Price ($)18.7559.01214.72%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)471.10600.7027.51%
P/S Multiple2.817.21156.29%
Shares Outstanding (Mil)70.7273.43-3.83%
Cumulative Contribution214.26%

LTM = Last Twelve Months as of date shown
The 143.8% change in LMND stock from 10/31/2022 to 10/30/2025 was primarily driven by a 251.3% change in the company's Total Revenues ($ Mil).

1031202210302025Change
Stock Price ($)24.2059.01143.84%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)171.00600.70251.29%
P/S Multiple8.757.21-17.54%
Shares Outstanding (Mil)61.8273.43-18.79%
Cumulative Contribution135.23%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
LMND Return--66%-68%18%127%61%-57%
Peers Return6%20%32%8%40%1%155%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
LMND Win Rate80%25%42%42%58%56% 
Peers Win Rate62%55%60%62%70%58% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
LMND Max Drawdown--68%-69%-23%-11%-32% 
Peers Max Drawdown-40%-5%-3%-16%-0%-7% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: PGR, MET, UNM, CB, TRV.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventLMNDS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-94.2%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven1633.8%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-45.4%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven83.1%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven39 days148 days

Compare to PGR, MET, UNM, CB, TRV


In The Past

Lemonade's stock fell -94.2% during the 2022 Inflation Shock from a high on 1/11/2021. A -94.2% loss requires a 1633.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Lemonade (LMND)

Better Bets than Lemonade (LMND)

 LMNDBetter Performance than LMND
MetricValueIndustry (Property & Casualty Insurance)
Rev Chg LTM27.5%PLMR (52.3%), ROOT (59.8%), SLDE (47.5%), HIPO (43.1%), BOW (41.2%)
Rev Chg 3Y Avg56.5%WTM (95.8%), ROOT (78.9%), HIPO (60.1%), ACIC (233.8%)
CFO/Rev LTM-1.9%PGR (20.4%), CB (22.6%), TRV (20.6%), ALL (13.2%), HIG (21.6%)
FCF/Rev LTM-3.6%PGR (20.0%), CB (22.6%), TRV (20.6%), ALL (12.9%), HIG (21.2%)
Total Yield-4.7%PGR (11.0%), CB (10.1%), TRV (10.5%), ALL (13.4%), HIG (11.9%)
 LMNDBetter Performance than LMND
MetricValueAll Other Sectors
Rev Chg LTM27.5%NVDA (71.6%), AVGO (28.0%), LLY (36.8%), PLTR (38.8%), MU (48.9%)
Rev Chg 3Y Avg56.5%NVDA (92.0%), RKLB (58.4%), SMCI (64.7%), NBIS (160.6%), CRDO (74.4%)
CFO/Rev LTM-1.9%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM-3.6%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AMZN (2.0%)
Total Yield-4.7%NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)
 Best Bets In Financials Sector
 LMNDDBRG OTF MTG NMIH CACC ENVA FNF ACGL APAM FI
What You Pay           
P/E-21.239.713.28.47.512.310.213.98.610.510.6
P/EBIT�64.79.06.45.59.97.88.97.66.15.8
What You Get           
Rev Chg Q34.5%-102.4%1,228.5%-0.7%7.2%8.3%16.3%16.8%22.4%4.4%8.0%
Rev Chg LTM27.5%-84.8%89.0%2.2%10.0%12.5%21.1%7.4%23.5%10.0%6.7%
Rev Chg 3Y Avg56.5%125.8%221.9%1.2%10.1%6.9%23.5%-0.7%29.8%0.2%7.5%
FCF/Rev 3Y Avg-23.8%101.2%76.2%62.2%58.8%57.1%54.7%50.8%38.4%29.0%20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

Trade Ideas

Select past ideas related to LMND. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Lemonade

Financials

LMNDPGRMETUNMCBTRVMedian
NameLemonade Progress.MetLife Unum Chubb Traveler. 
Mkt Price59.01206.9779.1673.50278.06271.01143.06
Mkt Cap4.3121.353.112.8110.560.756.9
Rev LTM60182,37672,07812,82858,90048,40953,654
Op Inc LTM-------
FCF LTM-2116,47215,2291,44413,3219,98511,653
FCF 3Y Avg-9512,35013,7931,22313,4098,68210,516
CFO LTM-1216,80015,2291,57713,3219,98511,653
CFO 3Y Avg-8512,63413,7931,35113,4098,68210,658

Growth & Margins

LMNDPGRMETUNMCBTRVMedian
NameLemonade Progress.MetLife Unum Chubb Traveler. 
Rev Chg LTM27.5%21.5%5.9%2.0%6.7%6.7%6.7%
Rev Chg 3Y Avg56.5%20.0%6.0%2.9%12.2%10.1%11.2%
Rev Chg Q34.5%21.3%-1.8%4.4%8.2%4.8%6.5%
QoQ Delta Rev Chg LTM7.5%4.9%-0.4%1.1%2.2%1.2%1.7%
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM-1.9%20.4%21.1%12.3%22.6%20.6%20.5%
CFO/Rev 3Y Avg-21.7%18.0%19.7%10.8%24.8%19.4%18.7%
FCF/Rev LTM-3.6%20.0%21.1%11.3%22.6%20.6%20.3%
FCF/Rev 3Y Avg-23.8%17.6%19.7%9.8%24.8%19.4%18.5%

Valuation

LMNDPGRMETUNMCBTRVMedian
NameLemonade Progress.MetLife Unum Chubb Traveler. 
Mkt Cap4.3121.353.112.8110.560.756.9
P/S7.21.50.71.01.91.31.4
P/EBIT-9.07.96.08.47.97.9
P/E-21.211.612.48.411.410.310.9
P/CFO-373.67.23.58.18.36.16.7
Total Yield-4.7%11.0%10.9%14.3%10.1%10.5%10.7%
Dividend Yield0.0%2.4%2.9%2.4%1.3%0.8%1.9%
FCF Yield 3Y Avg-7.7%10.3%28.1%11.2%12.9%17.2%12.1%
D/E0.00.10.40.30.20.20.2
Net D/E-0.1-0.0-1.7-2.8-0.2-1.5-0.8

Returns

LMNDPGRMETUNMCBTRVMedian
NameLemonade Progress.MetLife Unum Chubb Traveler. 
1M Rtn10.2%-16.2%-3.9%-4.9%-1.5%-2.9%-3.4%
3M Rtn56.6%-14.5%4.2%3.0%4.9%4.6%4.4%
6M Rtn107.0%-25.4%6.0%-3.9%-1.2%4.5%1.7%
12M Rtn214.7%-13.1%-2.1%16.8%-0.7%10.2%4.7%
3Y Rtn143.8%66.0%18.6%75.2%35.2%55.7%60.8%
1M Excs Rtn10.9%-17.7%-5.0%-7.2%-2.8%-3.9%-4.5%
3M Excs Rtn52.7%-23.5%-2.4%-3.3%-5.0%-4.0%-3.7%
6M Excs Rtn85.2%-47.1%-15.7%-25.7%-22.9%-17.2%-20.1%
12M Excs Rtn199.4%-30.7%-19.1%4.4%-20.0%-8.0%-13.6%
3Y Excs Rtn77.3%-2.2%-54.4%3.0%-32.5%-13.7%-8.0%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/5/20255/6/20252/26/202510/31/20247/31/20245/1/20242/28/202411/3/20238/4/20235/5/20233/3/202311/9/2022
Key Financials Quarterly            
Total Revenue164151149137122119116114105958874
Net Income-44-62-30-68-57-47-42-62-67-66-64-91
EPS-0.60-0.86-0.41-0.95-0.81-0.67-0.60-0.88-0.97-0.95-0.90-1.37
Key Financials TTM            
Total Revenue TTM601559526493471454430403362308257209
Net Income TTM-204-217-202-215-208-218-237-258-288-289-298-304
Growth Rates Quarterly            
Total Revenue Growth34.5%27.0%28.8%19.3%16.6%25.1%30.7%54.7%109.2%114.9%115.6%107.3%
Net Income Growth23.3%-31.9%29.2%-10.1%14.9%28.1%33.4%32.7%1.0%12.0%9.4%-37.7%
Margins Quarterly            
Net Income Margin-26.8%-41.3%-20.2%-49.6%-46.9%-39.7%-36.7%-53.7%-64.2%-69.1%-72.1%-123.5%
Cash & Debt            
Total Cash6706401,0115859249219385585609881,0331,058
Total Debt144124107896754433732343537
Net Debt / (Cash)-527-516-904-496-857-866-895-521-529-954-997-1,021
Cash Flows Quarterly            
FCF from Operations6-471416-12-30-16-6-50-46-29-55
Cash Flows TTM            
FCF from Operations TTM-12-29-11-41-64-102-119-132-180-170-163-184
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC-12.1%-17.7%-12.1%-19.3%-22.5%-19.0%-17.4%-18.9%-21.3%-32.6%-34.9%-52.3%
Return on Invested Capital (ROIC) TTM            
ROIC TTM-14.5%-15.6%-20.5%-15.1%-20.4%-22.0%-25.2%-20.5%-23.3%-36.2%-40.4%-43.3%

Price Behavior

LMND Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta3.251.581.491.781.892.02
Up Beta-1.251.071.711.821.991.91
Down Beta6.701.610.661.871.531.47
Up Capture257%344%215%261%682%4275%
Bmk +ve Days13233574144420
Stock +ve Days9213063126352
Down Capture475%48%142%133%132%110%
Bmk -ve Days8192952107330
Stock -ve Days12213360121394

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity15,644,907
Short Interest: % Change Since 9302025-4.1%
Average Daily Volume2,276,733
Days-to-Cover Short Interest6.87
Basic Shares Quantity73,433,379
Short % of Basic Shares21.3%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/5/20256.6%13.9%5.8%
5/6/20251.0%6.6%19.5%
2/25/2025-1.6%16.6%7.2%
10/30/202426.8%56.2%176.3%
7/30/2024-20.3%-31.4%-21.9%
2/27/2024-27.7%-24.8%-25.0%
11/1/202347.0%45.5%66.4%
8/2/2023-21.6%-29.1%-37.7%
...
SUMMARY STATS   
# Positive91210
# Negative11810
Median Positive6.6%15.3%28.4%
Median Negative-6.7%-12.2%-19.7%
Max Positive47.0%56.2%176.3%
Max Negative-27.7%-31.4%-37.7%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025805202510-Q 6/30/2025
3312025506202510-Q 3/31/2025
12312024226202510-K 12/31/2024
93020241031202410-Q 9/30/2024
6302024731202410-Q 6/30/2024
3312024501202410-Q 3/31/2024
12312023228202410-K 12/31/2023
93020231103202310-Q 9/30/2023
6302023804202310-Q 6/30/2023
3312023505202310-Q 3/31/2023
12312022303202310-K 12/31/2022
93020221109202210-Q 9/30/2022
6302022809202210-Q 6/30/2022
3312022510202210-Q 3/31/2022
12312021301202210-K 12/31/2021
93020211109202110-Q 9/30/2021

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.